Capricor Therapeutics | CAPR - Operating Profit

Stock Price
34.10
Daily Change
1.14 3.46%
Monthly
6.66%
Yearly
394.92%
Q2 Forecast
30.27

Capricor Therapeutics reported $-29.16M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Bioline Rx USD -2.21M 96K Sep/2025
Capricor Therapeutics USD -29.16M 2.87M Dec/2025
Cipla INR 9.77B 6.21B Dec/2025
Cytokinetics USD -181.23M 2.86M Mar/2026
Geron USD -10.79M 3.1M Dec/2025
Grifols EUR 320.55M 91.01M Dec/2025
Immunic USD -23.33M 2.67M Dec/2025
J&J USD 6.62B 1.03B Mar/2026
Plus Therapeutics USD -5.74M 1.26M Dec/2025
Prothena USD -27.21M 12.55M Dec/2025
PTC Therapeutics USD -81.62M 85.11M Dec/2025
Sarepta Therapeutics USD -410.08M 347.2M Dec/2025